CytoDyn Inc. (CYDY) is Tackling HIV Differently
Nestled on the north bank of the Columbia River in the State of Washington is the city of Vancouver, home to CytoDyn Inc. (OTCQB: CYDY). A publicly-held biotech company, CytoDyn manages its efforts to improve the lives of men and women with the human immunodeficiency virus (HIV), focusing its attention on developing new therapies that offer flexibility and freedom to members of this global community. With its lead clinical drug candidate, PRO 140, CytoDyn is aiming to offer the next class of antiviral agents for the treatment of HIV. The drug, a monoclonal antibody, is designed to block HIV from…







